Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Profiling of Gene Expression According to Cancer Stage in Clear Cell Type of Renal Cell Carcinoma

  • Won, Nam-Hee (Department of Pathology and Korea University Medical School) ;
  • Ryu, Yeon-Mi (Department of Biochemistry & Molecular biology, Korea University Medical School) ;
  • Kim, Ki-Nam (Department of Biochemistry & Molecular biology, Korea University Medical School) ;
  • Kim, Meyoung-Kon (Department of Biochemistry & Molecular biology, Korea University Medical School)
  • Published : 2005.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

For toxicity model in the kidney, renal cell carcinoma (RCC) is one of the most important model to assess the structural and functional alterations. Most RCCs are sporadic, and environmental agents are suspected to play a role in the etiology of the disease. In this study, we discovered novel evidence for previously unknown gene expression patterns related to progression according to cancer stage in RCC. Four clear cell RCC tissue samples along with five corresponding patient-matched normal kidney tissue samples were obtained from patients undergoing partial or radical nephrectomy. To examine the difference of gene expression profile in clear cell RCC, radioactive cDNA microarrays were used to evaluate changes in the expression of 1,152 genes in a total. Using $^{33}P-labeled$ probes, this method provided highly sensitive gene expression profiles including drug metabolism, and cellular signaling. 29 genes were identified with expression levels that differed by more than 2.0 value of z-ratio, compared with that in control. Whereas expression of 38 genes were decreased by less than-2.0 value of z-ratio. In conclusion, this study has identified 67 gene expression alterations in clear-cell type of RCC. Most notably, genes involved in cell growth were up-regulated in stage I more than stage III whereas genes involved in signal transduction were down-regulated in which both stage I and stage III. The identified alteraions of gene expression will likely give in sight in to clear cell RCC and tumor progression.

Keywords

References

  1. Higgins, J. et al. Gene expression pattern in Renal cell carcinoma assessed by Complementary DNA microarray. Am J Pathol. 162(3), 925-32 (2003)
  2. Yao, M. et al. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol. 205(3), 377-87 (2005) https://doi.org/10.1002/path.1693
  3. Yang, X.J. et al. A Gene expression profiling of renal medullary carcinoma Cancer. Mar Cancer. 100 (5), 976-85 (2004) https://doi.org/10.1002/cncr.20049
  4. Liou, L.S. et al. Microarray gene expression profiling and analysis in renal cell carcinoma. BMC Urol. 4(1), 9 (2004) https://doi.org/10.1186/1471-2490-4-4
  5. Struckmann, K. et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res. 64(5), 1632-8 (2004) https://doi.org/10.1158/0008-5472.CAN-03-1687
  6. Ficarra, V., Novara, G., Galfano, A. & Artibani, W. Neoplasm staging and organ-confined renal cell carcinoma: A systematic review. Eur Urol. 46(5), 559- 64 (2004) https://doi.org/10.1016/j.eururo.2004.07.002
  7. Semenza, J.C., Ziogas, A., Largent, J., Peel, D. & Anton-Culver, H. Gene-Environment Interactions in renal cell carcinoma. Am J Epidemiol. 153(9), 851-9 (2001) https://doi.org/10.1093/aje/153.9.851
  8. Boer, J.M. et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 11, 1861-70 (2001)
  9. Kim, Y.H. et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med. 35(5), 336-49 (2003) https://doi.org/10.1038/emm.2003.45
  10. Vawter et al. Application of cDNA microarrays to examine gene expression differences in schizophrena. Brain Res. Bull. 55, 641-50 (2001)
  11. Tanaka et al. Genome-wide expression profiling of mid-gestation palcenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci. USA. 97, 9127-32 (2000) https://doi.org/10.1073/pnas.97.16.9127
  12. Eisen, M.B., Spellman, P.T., Brown P.O. & Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 95(25), 14863-8 (1998) https://doi.org/10.1073/pnas.95.25.14863
  13. Steiner, T., Knels, R. & Schubert, J. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol. 46(3), 327-30 (2004) https://doi.org/10.1016/j.eururo.2004.06.003
  14. Sachdev, D. & Yee, D. The IGF system and breast cancer. Endocr Relat Cancer. 8, 197-209 (2001) https://doi.org/10.1677/erc.0.0080197
  15. Yu, H. & Rohan, T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst. 92, 1472-1489 (2000) https://doi.org/10.1093/jnci/92.18.1472
  16. Grimberg, A. & Cohen, P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 183, 1-9 (2000) https://doi.org/10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J
  17. Feldman, W.C. et al. Global distribution of neutrons from Mars: Results from Mars Odyssey. Science 297, 75-78 (2002) https://doi.org/10.1126/science.1073541
  18. Vestey, S.B., Perks, C.M., Sen, C., Calder, C.J., Holly, J.M. & Winters, Z.E. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Breast Cancer Res. 7(1), R119-R129 (2005) https://doi.org/10.1186/bcr963
  19. Hu, Y et al. 90-kDa ribosomal S6 kinase is a direct target for the nuclear fibroblast growth factor receptor 1 (FGFR1): role in FGFR1 signaling. J. Biol Chem. 279(28), 29325-35 (2004) https://doi.org/10.1074/jbc.M311144200
  20. Radhakrishna, H., Al-Awar, O., Khachikian, Z. & Donaldson, J.G. ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements. J Cell Sci. 112, 855-866 (1999)
  21. Ushio-Fukai, M. et al. Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res. 91, 1160-1167 (2002) https://doi.org/10.1161/01.RES.0000046227.65158.F8
  22. Ikeda, S. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res. 96(4), 467-75 (2005) https://doi.org/10.1161/01.RES.0000158286.51045.16
  23. Matsuyama, M. et al. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol. 24(4), 821-7 (2004)
  24. Johnson, K.W. & Smith, KA. Molecular cloning of a novel human cdc2/CDC28-like protein kinase. J. Biol Chem. 266(6), 3402-7 (1991)
  25. Lerman, B.B. Right ventricular outflow tract tachycardia due to a somatic cell mutation in G protein subunitalphai2. J. Clin Invest. 101(12), 2862-8 (1998) https://doi.org/10.1172/JCI551
  26. Yamada, K.M. & Olden, K. Fibronectins: adhesive glycoproteins of cell surface and blood. Nature 275, 179-84 (1978) https://doi.org/10.1038/275179a0
  27. Ohneda, K. & Yamamoto, M. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol. 108(4), 237-45 (2002) https://doi.org/10.1159/000065660
  28. Roberts, J.L. et al. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood. 103(6), 2009-18 (2004) https://doi.org/10.1182/blood-2003-06-2104
  29. Carinci, F. Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray. J. Oral Implantol. 29(5), 215-20 (2003) https://doi.org/10.1563/1548-1336(2003)029<0215:AOOMCR>2.3.CO;2
  30. Mangla, A. et al. Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses. Blood. 104(4), 1191-7 (2004) https://doi.org/10.1182/blood-2004-01-0207